Industry Insights Logo

Setting the Record Straight

SPONSORED CONTENT

The 340B program has come under increased scrutiny within the past five years. Opponents often claim it is misused by covered entities (CEs) to generate profits rather than help vulnerable patients. These criticisms often come from a misunderstanding of

Read More »

340B INDUSTRY LEADER SPOTLIGHT

Abel Haile, Senior Director, Health System Strategy & Commercial Analytics, Maxor National Pharmacy Services

Abel Haile

Q: Where did you grow up?

My family moved to the United States from Ethiopia when I was two years old, and I spent my childhood in the northwestern suburbs of Chicago.

Q: Where did you go to college/graduate school?

I went to the University of Illinois, Urbana Champaign.

Q: What are your favorites?

Food:  Probably easier

Read More »
Industry Insights Logo

How to Maximize Partner Support for Referral Capture During a HRSA Audit

SPONSORED CONTENT

A HRSA audit is not a question of if but when. Therefore, it is crucial for covered entities (CEs) to always remain audit-ready. The 340B program has become increasingly complex over the years, prompting service provider partners (partners) in the

Read More »

340B INDUSTRY LEADER SPOTLIGHT

Justin Rolling, CaptureRx

Justin Rolling

Q: Where did you grow up?

I grew up in rural southeast Alabama in the small town of Luverne.

Q: Where did you go to college/graduate school?

I attended Troy University for both my Bachelor’s Degree and Master’s Degree and both are in accounting. I also have my CPA license. 

Q: What are your favorites?

Food:  BBQ

Read More »
Industry Insights Logo

Effective Contract Pharmacy Strategies in an Ever-Changing Landscape

SPONSORED CONTENT

W. Edwards Deming is a renowned statistician and expert in quality management. He is often quoted as saying, “Uncontrolled variation is the enemy of quality.” In the realm of 340B, including 340B contract pharmacies, that change is both continual and constant.

Read More »
Industry Insights Logo

Navigating Uncertainty: Reflections from the 340B Coalition Winter Conference 

SPONSORED CONTENT

Let me start by saying that I have been to the 340B Coalition conferences since 2012, and every year entities have feared significant changes and the threat of problematic legislation becoming law. Fortunately,

Read More »
Industry Insights Logo

Fireside Chat: Strategies for Measuring Success & Ensuring Compliance in Your 340B Program

SPONSORED CONTENT

The 340B program serves as a critical resource for hospitals and other safety net providers striving to provide comprehensive care to their patient populations. However, evolving operational requirements make it essential for covered entities to develop programs that are both scalable and

Read More »

Expert Tip from SunRx

img
img

TIP: Take time to focus on these three important fundamentals of 340B program compliance and integrity.


Update

Read More »
Industry Insights Logo

On Demand Webinar—What’s Next for Covered Entities? Navigating 340B Challenges and the Future of Patient Care

SPONSORED CONTENT

The 340B Drug Pricing Program is at a crossroads, facing increased scrutiny, manufacturer restrictions, and ongoing legal battles. In this must-watch webinar, industry experts Ted Slafsky (340B Report), Emily Cook (McDermott, Will & Emery), and Nicole Shoquist (JPS Health Network) break down the

Read More »
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live